Loading...

Ramin Morshed, MD

Title(s)Resident, Neurological Surgery
SchoolSchool of Medicine
Phone415-353-3811
ORCID ORCID Icon0000-0001-8464-6041 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Breshears JD, Morshed RA, Molinaro AM, McDermott MW, Cheung SW, Theodosopoulos PV. Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study. Neurosurgery. 2020 Mar 01; 86(3):410-416. PMID: 31232426.
      View in: PubMed
    2. Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 Feb 06. PMID: 32027343.
      View in: PubMed
    3. Breshears JD, Morshed RA, Theodosopoulos PV. In Reply: Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study. Neurosurgery. 2020 Feb 01; 86(2):E238. PMID: 31690926.
      View in: PubMed
    4. Ramin Morshed, Sheantel Reihl, Sofia Kakaizada, Eric Zhang, Jacob Young, Jennifer Clarke, Nicholas Butowski, Jennie Taylor, Nancy Ann Oberheim-Bush, Manish Aghi, Mitchel Berger, Susan Chang, Shawn Hervey-Jumper. ACTR-35. A STUDY OF RACE AND SOCIOECONOMIC STATUS IMPACTING THERAPEUTIC CLINICAL TRIAL ENROLLMENT IN ADULT GLIOMAS PATIENTS. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi21-vi21.
      View in: Publisher Site
    5. Ramin Morshed, Melike Pekmezci, Jacob Young, Manish Aghi, Mike McDermott, Philip Theodosopoulos, Mitchel Berger, Shawn Hervey-Jumper. SURG-20. IDENTIFICATION OF INFILTRATIVE CANCER CELLS AT THE GLIOMA RESECTION CAVITY MARGIN USING STIMULATED RAMAN SCATTERING MICROSCOPY. Neuro-Oncology. 2019 Nov 11; 21(Supplement_6):vi243-vi244.
      View in: Publisher Site
    6. Young JS, Morshed RA, Mansoori Z, Cha S, Berger MS. Disruption of Frontal Aslant Tract Is Not Associated with Long-Term Postoperative Language Deficits. World Neurosurg. 2020 Jan; 133:192-195. PMID: 31574328.
      View in: PubMed
    7. Ramin A Morshed, Daniel Murph, Jasmin Dao, Kathleen Colao, Lauro Avalos, Steven Hetts, Adib A Abla, Christine Fox, Michael T Lawton, Nalin Gupta. Clinical and Imaging Outcomes After Combined Direct and Indirect Bypass for Pediatric Moyamoya Disease: A Single Center Retrospective Series. Neurosurgery. 2019 Sep 1; 66(Supplement_1).
      View in: Publisher Site
    8. Morshed RA, Wu SY, Sneed PK, McDermott MW. Radiotherapy for recurrent intracranial epidermoid cysts without malignant transformation: a single-institution case series. J Neurooncol. 2019 Aug; 144(1):89-96. PMID: 31168670.
      View in: PubMed
    9. Morshed RA, Lee AT, Lee YM, Chin CT, Jacques L. Schwannomatosis of the Spinal Accessory Nerve: A Case Report. J Brachial Plex Peripher Nerve Inj. 2019 Jan; 14(1):e9-e13. PMID: 31037098.
      View in: PubMed
    10. Spencer D, Yu D, Morshed RA, Li G, Pituch KC, Gao DX, Bertolino N, Procissi D, Lesniak MS, Balyasnikova IV. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma. Theranostics. 2019; 9(7):2071-2083. PMID: 31037157.
      View in: PubMed
    11. Morshed RA, Young JS, Hervey-Jumper SL, Berger MS. The management of low-grade gliomas in adults. J Neurosurg Sci. 2019 Aug; 63(4):450-457. PMID: 30916536.
      View in: PubMed
    12. Morshed RA, Young JS, Safaee M, Sankaran S, Berger MS, McDermott MW, Hervey-Jumper SL. Delirium Risk Factors and Associated Outcomes in a Neurosurgical Cohort: A Case-Control Study. World Neurosurg. 2019 Jun; 126:e930-e936. PMID: 30872201.
      View in: PubMed
    13. Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS. The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes. J Neurosurg. 2019 Mar 01; 130(3):822-830. PMID: 29676697.
      View in: PubMed
    14. Young JS, Dayani F, Morshed RA, Okada H, Aghi MK. Immunotherapy for High Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. World Neurosurg. 2019 Jan 21. PMID: 30677574.
      View in: PubMed
    15. Morshed RA, Han SJ, Hervey-Jumper SL, Pekmezci M, Troncon I, Chang SM, Butowski NA, Berger MS. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60. J Neurooncol. 2019 Jan; 141(2):383-391. PMID: 30498891.
      View in: PubMed
    16. Annette Molinaro, Shawn Hervey-Jumper, Seunggu J. Han, Ramin Morshed, Marisa Lafontaine, Nicole Ebrahimi, Jacob Young, Joanna J Phillips, Anny Shai, Gayathri Warrier, Terri Rice, Yi Lin, Jason Crane, Sarah Nelson, Margaret Wrensch, John Wiencke, Arie Perry, Nancy Ann Oberheim Bush, Jennie Taylor, Nicholas Butowski, Michael Prados, Jennifer Clarke, Susan Chang, Edward Chang, Manish Aghi, Philip Theodosopoulos, Michael McDermott, Mitchel Berger. SURG-02. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. 2018 Nov 5; 20(suppl_6):vi250-vi250.
      View in: Publisher Site
    17. Morshed RA, Young JS, Han SJ, Hervey-Jumper SL, Berger MS. Perioperative outcomes following reoperation for recurrent insular gliomas. J Neurosurg. 2018 09 21; 131(2):467-473. PMID: 30239317.
      View in: PubMed
    18. Michael Safaee, Ramin A Morshed, Jordan Spatz, Sujatha Sankaran, Mitchel S Berger, Manish K Aghi. 334 Interfacility Neurosurgical Transfers: An Analysis of Nontraumatic Inpatient and Emergency Department Transfers With Implications for Improvements In Care. Neurosurgery. 2018 Sep 1; 65(CN_suppl_1):134-134.
      View in: Publisher Site
    19. Han SJ, Morshed RA, Troncon I, Jordan KM, Henry RG, Hervey-Jumper SL, Berger MS. Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases. J Neurosurg. 2018 Aug 17; 131(1):201-208. PMID: 30117770.
      View in: PubMed
    20. Safaee MM, Morshed RA, Spatz J, Sankaran S, Berger MS, Aghi MK. Interfacility neurosurgical transfers: an analysis of nontraumatic inpatient and emergency department transfers with implications for improvements in care. J Neurosurg. 2018 Aug 03; 131(1):281-289. PMID: 30074453.
      View in: PubMed
    21. Morshed RA, Young JS, Hervey-Jumper SL. Sharpening the Surgeon's Knife: Value of Extent of Resection for Glioma in Molecular Age. World Neurosurg. 2018 09; 117:350-352. PMID: 29945007.
      View in: PubMed
    22. Magill ST, Morshed RA, Lucas CG, Aghi MK, Theodosopoulos PV, Berger MS, de Divitiis O, Solari D, Cappabianca P, Cavallo LM, McDermott MW. Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach. Neurosurg Focus. 2018 04; 44(4):E9. PMID: 29606045.
      View in: PubMed
    23. Seunggu Jude Han, Irene Troncon, Ramin Morshed, Kesshi Jordan, Roland Henry, Mitchel S Berger. SURG-03. SUBCORTICAL STIMULATION MAPPING OF DESCENDING MOTOR PATHWAYS FOR PERIROLANDIC GLIOMAS: ASSESSMENT OF MORBIDITY AND FUNCTIONAL OUTCOME IN OVER 700 PATIENTS. Neuro-Oncology. 2017 Nov 6; 19(suppl_6):vi235-vi236.
      View in: Publisher Site
    24. Morshed RA, Lau D, Sun PP, Ostling LR. Spinal drop metastasis from a benign fourth ventricular choroid plexus papilloma in a pediatric patient: case report. J Neurosurg Pediatr. 2017 Nov; 20(5):471-479. PMID: 28841111.
      View in: PubMed
    25. Moughamian AJ, Morshed RA, Colorado RA, Liner Z, Cooke D, Hemphill JC. Teaching NeuroImages: Artery of Percheron aneurysm masquerading as ICH spot sign. Neurology. 2017 08 08; 89(6):e64-e65. PMID: 28784644.
      View in: PubMed
    26. Morshed RA, Han SJ, Lau D, Berger MS. Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note. J Neurosurg. 2018 05; 128(5):1448-1453. PMID: 28665248.
      View in: PubMed
    27. Morshed RA, Muroski ME, Dai Q, Wegscheid ML, Auffinger B, Yu D, Han Y, Zhang L, Wu M, Cheng Y, Lesniak MS. Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer. Mol Pharm. 2016 06 06; 13(6):1843-54. PMID: 27169484.
      View in: PubMed
    28. Muroski ME, Morshed RA, Cheng Y, Vemulkar T, Mansell R, Han Y, Zhang L, Aboody KS, Cowburn RP, Lesniak MS. Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment. PLoS One. 2016; 11(1):e0145129. PMID: 26734932.
      View in: PubMed
    29. Kim JW, Morshed RA, Kane JR, Auffinger B, Qiao J, Lesniak MS. Viral Vector Production: Adenovirus. Methods Mol Biol. 2016; 1382:115-30. PMID: 26611583.
      View in: PubMed
    30. Cheng Y, Muroski ME, Petit DCMC, Mansell R, Vemulkar T, Morshed RA, Han Y, Balyasnikova IV, Horbinski CM, Huang X, Zhang L, Cowburn RP, Lesniak MS. Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma. J Control Release. 2016 Feb 10; 223:75-84. PMID: 26708022.
      View in: PubMed
    31. Cheng SH, Yu D, Tsai HM, Morshed RA, Kanojia D, Lo LW, Leoni L, Govind Y, Zhang L, Aboody KS, Lesniak MS, Chen CT, Balyasnikova IV. Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma. J Nucl Med. 2016 Feb; 57(2):279-84. PMID: 26564318.
      View in: PubMed
    32. Cahill KE, Morshed RA, Yamini B. Nuclear factor-?B in glioblastoma: insights into regulators and targeted therapy. Neuro Oncol. 2016 Mar; 18(3):329-39. PMID: 26534766.
      View in: PubMed
    33. Kim JW, Kane JR, Young JS, Chang AL, Kanojia D, Morshed RA, Miska J, Ahmed AU, Balyasnikova IV, Han Y, Zhang L, Curiel DT, Lesniak MS. A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma. Hum Gene Ther. 2015 Sep; 26(9):635-46. PMID: 26058317.
      View in: PubMed
    34. Kanojia D, Balyasnikova IV, Morshed RA, Frank RT, Yu D, Zhang L, Spencer DA, Kim JW, Han Y, Yu D, Ahmed AU, Aboody KS, Lesniak MS. Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells. 2015 Oct; 33(10):2985-94. PMID: 26260958.
      View in: PubMed
    35. Kanojia D, Morshed RA, Zhang L, Miska JM, Qiao J, Kim JW, Pytel P, Balyasnikova IV, Lesniak MS, Ahmed AU. ßIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Mol Cancer Ther. 2015 May; 14(5):1152-61. PMID: 25724666.
      View in: PubMed
    36. Julius W. Kim, J. Robert Kane, Jacob S. Young, Ramin A. Morshed, Alan A. Chang, Atique U. Ahmed, Irina V. Balyasnikova, Maciej S. Lesniak. ET-29AN OPTIMIZED ONCOLYTIC ADENOVIRUS FOR GLIOMA THERAPY: SPECIFIC TARGETING, EFFICIENT INFECTION, AND RESTRICTED REPLICATION IN GLIOMA. Neuro-Oncology. 2014 Nov 1; 16(suppl_5):v85-v86.
      View in: Publisher Site
    37. Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, Han Y, Zhang L, Auffinger B, Tobias AL, Rincón E, Thaci B, Ahmed AU, Warnke PC, He C, Lesniak MS. Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small. 2014 Dec 29; 10(24):5137-50. PMID: 25104165.
      View in: PubMed
    38. Young JS, Morshed RA, Kim JW, Balyasnikova IV, Ahmed AU, Lesniak MS. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy. Expert Opin Drug Deliv. 2014 Nov; 11(11):1733-46. PMID: 25005767.
      View in: PubMed
    39. Wegscheid ML, Morshed RA, Cheng Y, Lesniak MS. The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma. Expert Opin Drug Deliv. 2014 Jun; 11(6):957-75. PMID: 24766329.
      View in: PubMed
    40. Morshed RA, Cheng Y, Auffinger B, Wegscheid ML, Lesniak MS. The potential of polymeric micelles in the context of glioblastoma therapy. Front Pharmacol. 2013 Dec 30; 4:157. PMID: 24416018.
      View in: PubMed
    41. Chung EJ, Cheng Y, Morshed R, Nord K, Han Y, Wegscheid ML, Auffinger B, Wainwright DA, Lesniak MS, Tirrell MV. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials. 2014 Jan; 35(4):1249-56. PMID: 24211079.
      View in: PubMed
    42. Cheng Y, Morshed RA, Auffinger B, Tobias AL, Lesniak MS. Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev. 2014 Feb; 66:42-57. PMID: 24060923.
      View in: PubMed
    43. Cheng Y, Morshed R, Cheng SH, Tobias A, Auffinger B, Wainwright DA, Zhang L, Yunis C, Han Y, Chen CT, Lo LW, Aboody KS, Ahmed AU, Lesniak MS. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small. 2013 Dec 20; 9(24):4123-9. PMID: 23873826.
      View in: PubMed
    44. Auffinger B, Morshed R, Tobias A, Cheng Y, Ahmed AU, Lesniak MS. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Oncotarget. 2013 Mar; 4(3):378-96. PMID: 23594406.
      View in: PubMed